Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 06 04:00PM ET
59.80
Dollar change
+0.15
Percentage change
0.25
%
IndexRUT P/E- EPS (ttm)-2.16 Insider Own13.65% Shs Outstand39.03M Perf Week0.17%
Market Cap2.33B Forward P/E- EPS next Y-2.76 Insider Trans-0.93% Shs Float33.70M Perf Month77.82%
Income-64.74M PEG- EPS next Q-0.58 Inst Own101.84% Short Float15.34% Perf Quarter61.67%
Sales0.00M P/S- EPS this Y7.95% Inst Trans1.77% Short Ratio3.18 Perf Half Y175.58%
Book/sh7.58 P/B7.89 EPS next Y-25.52% ROA-34.15% Short Interest5.17M Perf Year1041.22%
Cash/sh7.81 P/C7.66 EPS next 5Y- ROE-36.71% 52W Range3.60 - 59.95 Perf YTD891.71%
Dividend Est.- P/FCF- EPS past 5Y- ROI-21.71% 52W High-0.25% Beta1.05
Dividend TTM- Quick Ratio20.95 Sales past 5Y0.00% Gross Margin- 52W Low1561.11% ATR (14)1.42
Dividend Ex-Date- Current Ratio20.95 EPS Y/Y TTM15.11% Oper. Margin0.00% RSI (14)80.85 Volatility0.59% 1.68%
Employees50 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom2.43 Target Price68.29
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q14.20% Payout- Rel Volume0.93 Prev Close59.65
Sales Surprise- EPS Surprise-27.10% Sales Q/Q- EarningsAug 01 AMC Avg Volume1.63M Price59.80
SMA204.56% SMA5038.80% SMA200106.00% Trades Volume1,501,394 Change0.25%
Date Action Analyst Rating Change Price Target Change
Sep-10-24Initiated Truist Buy $60
Jul-01-24Reiterated Cantor Fitzgerald Overweight $60 → $90
May-01-24Initiated Robert W. Baird Outperform $36
Feb-16-24Initiated Citigroup Buy $40
Oct-24-23Resumed Cantor Fitzgerald Overweight $16 → $35
Apr-27-23Initiated B. Riley Securities Buy $13
Apr-07-21Initiated Evercore ISI Outperform $35
Apr-06-21Initiated Guggenheim Buy $27
Apr-06-21Initiated Citigroup Buy $37
Apr-06-21Initiated Cantor Fitzgerald Overweight $32
Oct-15-24 04:57PM
05:06AM
Oct-14-24 04:07PM
03:45PM
09:39AM
09:34AM Loading…
09:34AM
06:39AM
06:30AM
Oct-09-24 03:50PM
Oct-04-24 04:01PM
Sep-27-24 04:12AM
Sep-26-24 08:30AM
Sep-19-24 08:30AM
Sep-09-24 05:12AM
Sep-08-24 06:30AM
04:01PM Loading…
Sep-06-24 04:01PM
Aug-28-24 04:00PM
Aug-26-24 04:01PM
09:00AM
Aug-02-24 04:01PM
Aug-01-24 04:01PM
Jul-29-24 09:15AM
Jul-25-24 08:50AM
Jul-23-24 07:00AM
Jul-15-24 07:01PM
Jul-09-24 09:55AM
08:50AM
Jul-03-24 04:00PM
Jul-02-24 09:22AM
Jul-01-24 09:00AM
09:00AM Loading…
Jun-10-24 09:00AM
Jun-03-24 04:01PM
May-06-24 04:01PM
May-04-24 05:31AM
May-03-24 10:10AM
May-02-24 09:58PM
04:01PM
May-01-24 09:49AM
07:07AM
Apr-03-24 09:00AM
Apr-02-24 04:00PM
Mar-14-24 05:31AM
Mar-12-24 04:01PM
Mar-01-24 04:01PM
Feb-02-24 04:30PM
Feb-01-24 08:30AM
Jan-17-24 05:51AM
Jan-08-24 04:05PM
Jan-05-24 08:50AM
Jan-03-24 09:40PM
09:19AM
Jan-02-24 04:37PM
04:01PM
01:06PM
08:00AM
Jan-01-24 04:47PM
Nov-29-23 08:30AM
Nov-24-23 09:35AM
Nov-21-23 04:00PM
Nov-14-23 05:05PM
Nov-13-23 02:46PM
Nov-08-23 09:55AM
Nov-03-23 04:01PM
Nov-02-23 07:16PM
04:01PM
Nov-01-23 08:30AM
Oct-05-23 04:05PM
Sep-19-23 08:30AM
Aug-31-23 04:00PM
Aug-30-23 04:01PM
Aug-23-23 08:30AM
Aug-10-23 08:49AM
Aug-03-23 04:01PM
08:30AM
Jun-26-23 04:00PM
May-12-23 06:06AM
May-09-23 04:00PM
May-01-23 08:50AM
Apr-14-23 08:50AM
Apr-11-23 04:00PM
Apr-07-23 09:55AM
Apr-05-23 07:00AM
Mar-07-23 09:55AM
Mar-06-23 09:48AM
Mar-02-23 04:01PM
Feb-23-23 04:31PM
Feb-10-23 04:01PM
Feb-07-23 09:03PM
04:13PM
Jan-14-23 08:00AM
Dec-05-22 08:30AM
Nov-29-22 08:30AM
Nov-08-22 08:30AM
Nov-03-22 08:30AM
Oct-25-22 09:00AM
Sep-29-22 04:01PM
Sep-01-22 04:01PM
Aug-04-22 04:05PM
Aug-03-22 08:30AM
Jun-07-22 08:30AM
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaye RandallCMOOct 15 '24Option Exercise4.3516,66772,50134,587Oct 16 04:40 PM
Kaye RandallCMOOct 15 '24Sale59.0316,667983,93617,920Oct 16 04:40 PM
Kaye RandallCMOSep 16 '24Option Exercise4.3516,66672,49734,586Sep 16 07:36 PM
Kaye RandallCMOSep 16 '24Sale31.6416,666527,31817,920Sep 16 07:36 PM
RANDALL KAYEOfficerSep 16 '24Proposed Sale34.3233,3331,143,989Sep 16 04:35 PM
Lind Kevin RobertCEOAug 12 '24Option Exercise3.1582,482259,995430,932Aug 13 06:03 PM
Kaye RandallCMOAug 12 '24Option Exercise4.3516,66772,50134,587Aug 13 06:01 PM
Kaye RandallCMOJan 23 '24Buy24.821002,482100Aug 13 06:01 PM
Kaye RandallCMOAug 12 '24Sale34.7316,667578,80417,920Aug 13 06:01 PM
Kaye RandallCMOJun 25 '24Sale20.871002,0870Aug 13 06:01 PM
RANDALL KAYEOfficerAug 12 '24Proposed Sale35.0916,667584,845Aug 12 04:12 PM
ARENA PHARMACEUTICALS INCFormer 10% OwnerJan 25 '24Sale24.253,978,54096,479,5950Jan 29 04:37 PM